Bayer Boosts Finances With $2.6 Billion Covestro Stake Sale
- 14% holding remained after earlier selldowns of former unit
- JPMorgan and Bank of America are advising on the transaction
Bayer CEO 'Very Confident' About Closing Monsanto Deal
This article is for subscribers only.
Bayer AG sold its remaining stake in Covestro AG, raising 2.2 billion euros ($2.6 billion) as the German drugmaker closes in on the planned $66 billion purchase of genetically modified seeds supplier Monsanto Co.
Bayer sold 28.8 million, or 14 percent, of Covestro’s shares for 75.50 euros each, the company said in a statement on Friday. The transaction began after markets closed on Thursday and was managed by Bank of America Corp. and JPMorgan Chase and Co.